Huifeng Bio-Pharma Tech (PINK:HFGB)

	Recent 52-week high
	30% Earnings Per Share (EPS) growth rate
	10% revenue growth year over year
	Strong balance sheet
	15% minimum return on equity (ROE)
	8% minimum pre-tax margins
	Under 50 million shares outstanding
	High insider ownership
	Limited institutional ownership
	P/E at least 1/2 of EPS growth rate

It looks like Huifeng Bio-Pharma took a major step in its quest to up list its stock:

On May 6, 2010, Ms. Angela Aichun Li resigned as a member of the Board of Directors  of Huifeng Bio-Pharmaceutical Technology, Inc. Ms. Li’s resignation was due to personal reasons and not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

On May 8, 2010, the Board appointed Mr. Chi Keung Lui as a director of the Company, effective immediately. The Board has determined that Mr. Lui is an independent director.  Mr. Lui is currently the CEO of Porcheers Consultants Limited, a consulting company to provide professional services to corporations in internal control, public listing, acquisition and merger and corporate planning and investment. From 2004 to 2006, Mr. Lui was the Director and CFO of China Digital Media Corporation, a company listed on OTCBB. As the CFO of the China Digital Media Corporation, Mr. Lui assisted the company to be listed on OTCBB and to establish the accounting and financial system and implement the internal control system to comply with the U.S. listing requirements.